The AIM and EDA Concepts: Why They Are Needed and How They Fit Together - Good Cascade Impactor Practices, AIM and EDA for Orally Inhaled Products - page 129

22. Nasr MM (2006) Implementation of quality by design (QbD): status, challenges and next
steps, FDA Advisory Committee for Pharmaceutical Science Presentation (October 2006).
Available at http://www.fda.gov/ohrms/dockets/ac/06/slides/2006-4241s1_6.ppt . Accessed 10
Jan 2012
23. Mitchell JP, Copley M (2010) Accelerating inhaled product testing. Pharma Mag Jan/Feb:22-
25. Available at http://www.copleyscientifi c.com/documents/ww/COP%20JOB%20098_
Accelerating%20inhaled%20product%20testing.pdf . Accessed 5 Aug 2012
24. Tougas TP, Christopher D, Mitchell J, Lyapustina S, Van Oort M, Bauer R, Glaab V (2011)
Product lifecycle approach to cascade impaction measurements. AAPS PharmSciTech
12(1):312-322
25. Bonam M, Christopher D, Cipolla D, Donovan B, Goodwin D, Holmes S, Lyapustina S,
Mitchell J, Nichols S, Petterson G, Quale C, Rao N, Singh D, Tougas T, Van Oort M, Walther
B, Wyka B (2008) Minimizing variability of cascade impaction measurements in inhalers and
nebulizers. AAPS PharmSciTech 9(2):404-413
26. European Directorate for the Quality of Medicines and Healthcare (EDQM) (2012)
Preparations for nebulisation: characterisation. Section 2.9.44 - European Pharmacopeia,
Council of Europe, Strasbourg, France
27. Zhang Y, Finlay WH (2005) Experimental measurements of particle deposition in three proxi-
mal lung bifurcation models with an idealized mouth-throat. J Aerosol Med 18(4):460-473
28. Zhou Y, Sun J, Cheng Y-S (2011) Comparison of deposition in the USP and physical mouth-
throat models with solid and liquid particles. J Aerosol Med Pulm Drug Deliv 24(6):277-284
29. Tougas T (2011) Effi cient data analysis in quality assessment. In: Dalby RN, Byron PR, Peart
J, Suman JD, Young PM (eds) RDD Europe-2011. Davis Healthcare International, River
Grove, IL, pp 209-213
30. Mitchell J, Copley M (2010) EPAG-sponsored workshop on abbreviated impactor measure-
ment (AIM) concept in inhaler testing: overview of AIM-EDA. Drug Delivery to the Lungs-21,
The Aerosol Society, Edinburgh, UK, 21:370-373. Available at http://ddl-conference.org.uk/
index.php?q=previous_conferences . Accessed 4 Aug 2012
31. Mitchell JP, Tougas T, Christopher JD, Lyapustina S, Glaab V (2012) The abbreviated impac-
tor measurement and effi cient data analysis concepts: why use them and when. In: Dalby RN,
Byron PR, Peart J, Suman JD, Young PM (eds) Respiratory drug delivery 2012. Davis
Healthcare International, River Grove, IL, pp 731-736